Citigroup’s Pacira BioSciences PCRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$658K Sell
29,117
-5,825
-17% -$129K ﹤0.01% 3383
2025
Q4
$904K Buy
34,942
+4,147
+13% +$98.6K ﹤0.01% 3202
2025
Q3
$794K Sell
30,795
-21,637
-41% -$531K ﹤0.01% 3308
2025
Q2
$1.25M Sell
52,432
-32,504
-38% -$819K ﹤0.01% 3037
2025
Q1
$2.11M Buy
84,936
+7,377
+10% +$177K ﹤0.01% 2659
2024
Q4
$1.46M Sell
77,559
-13,030
-14% -$229K ﹤0.01% 3066
2024
Q3
$1.36M Buy
90,589
+48,786
+117% +$834K ﹤0.01% 3001
2024
Q2
$1.2M Buy
41,803
+3,780
+10% +$108K ﹤0.01% 2782
2024
Q1
$1.11M Sell
38,023
-1,096
-3% -$33.7K ﹤0.01% 2935
2023
Q4
$1.32M Sell
39,119
-14,042
-26% -$411K ﹤0.01% 2601
2023
Q3
$1.63M Buy
53,161
+9,668
+22% +$348K ﹤0.01% 2134
2023
Q2
$1.74M Buy
43,493
+15,301
+54% +$633K ﹤0.01% 2339
2023
Q1
$1.15M Sell
28,192
-4,469
-14% -$178K ﹤0.01% 2432
2022
Q4
$1.26M Buy
32,661
+3,541
+12% +$172K ﹤0.01% 2412
2022
Q3
$1.55M Buy
29,120
+639
+2% +$35.5K ﹤0.01% 2347
2022
Q2
$1.66M Sell
28,481
-21,121
-43% -$1.38M ﹤0.01% 2244
2022
Q1
$3.79M Buy
49,602
+4,878
+11% +$325K ﹤0.01% 1849
2021
Q4
$2.69M Sell
44,724
-15,296
-25% -$843K ﹤0.01% 2374
2021
Q3
$3.36M Buy
60,020
+10,270
+21% +$592K ﹤0.01% 2088
2021
Q2
$3.02M Buy
49,750
+23,995
+93% +$1.52M ﹤0.01% 2337
2021
Q1
$1.8M Sell
25,755
-10,655
-29% -$761K ﹤0.01% 2563
2020
Q4
$2.18M Buy
36,410
+5,412
+17% +$317K ﹤0.01% 2772
2020
Q3
$1.86M Sell
30,998
-15,545
-33% -$903K ﹤0.01% 2714
2020
Q2
$2.44M Buy
46,543
+14,980
+47% +$626K ﹤0.01% 2582
2020
Q1
$1.06M Sell
31,563
-8,680
-22% -$361K ﹤0.01% 3114
2019
Q4
$1.82M Buy
40,243
+8,330
+26% +$354K ﹤0.01% 3090
2019
Q3
$1.22M Sell
31,913
-8,942
-22% -$357K ﹤0.01% 3419
2019
Q2
$1.78M Buy
40,855
+8,191
+25% +$348K ﹤0.01% 2993
2019
Q1
$1.24M Sell
32,664
-16,404
-33% -$640K ﹤0.01% 3173
2018
Q4
$2.11M Sell
49,068
-4,348
-8% -$203K ﹤0.01% 2613
2018
Q3
$2.63M Buy
53,416
+16,455
+45% +$711K ﹤0.01% 2485
2018
Q2
$1.19M Sell
36,961
-1,358
-4% -$46.9K ﹤0.01% 3175
2018
Q1
$1.19M Sell
38,319
-6,437
-14% -$229K ﹤0.01% 3086
2017
Q4
$2.04M Sell
44,756
-29,761
-40% -$1.18M ﹤0.01% 2652
2017
Q3
$2.8M Sell
74,517
-22,264
-23% -$896K 0.01% 2314
2017
Q2
$4.62M Buy
96,781
+93,790
+3,136% +$4.35M 0.01% 1762
2017
Q1
$136K Sell
2,991
-10,623
-78% -$459K ﹤0.01% 4973
2016
Q4
$440K Sell
13,614
-49,927
-79% -$1.67M ﹤0.01% 4510
2016
Q3
$2.17M Buy
63,541
+55,981
+740% +$2.19M ﹤0.01% 2437
2016
Q2
$255K Sell
7,560
-29,900
-80% -$1.47M ﹤0.01% 4277
2016
Q1
$1.99M Buy
37,460
+17,428
+87% +$1.02M ﹤0.01% 2497
2015
Q4
$1.54M Sell
20,032
-9,465
-32% -$536K ﹤0.01% 2690
2015
Q3
$1.21M Sell
29,497
-2,667
-8% -$163K ﹤0.01% 2900
2015
Q2
$2.27M Buy
32,164
+400
+1% +$31.5K ﹤0.01% 2406
2015
Q1
$2.82M Buy
31,764
+11,091
+54% +$1.13M 0.01% 2191
2014
Q4
$1.83M Buy
20,673
+18,535
+867% +$1.75M ﹤0.01% 2540
2014
Q3
$207K Buy
2,138
+292
+16% +$28.4K ﹤0.01% 4213
2014
Q2
$170K Sell
1,846
-5,749
-76% -$438K ﹤0.01% 4266
2014
Q1
$531K Sell
7,595
-6,314
-45% -$429K ﹤0.01% 3413
2013
Q4
$799K Buy
13,909
+7,322
+111% +$385K ﹤0.01% 3390
2013
Q3
$317K Buy
6,587
+5,998
+1,018% +$219K ﹤0.01% 3803
2013
Q2
$18K Buy
+589
New +$17K ﹤0.01% 5868

Other funds holding PCRX